Literature DB >> 25728777

Dominant mutations in KAT6A cause intellectual disability with recognizable syndromic features.

Emma Tham1, Anna Lindstrand2, Avni Santani3, Helena Malmgren2, Addie Nesbitt4, Holly A Dubbs5, Elaine H Zackai5, Michael J Parker6, Francisca Millan7, Kenneth Rosenbaum8, Golder N Wilson9, Ann Nordgren2.   

Abstract

Through a multi-center collaboration study, we here report six individuals from five unrelated families, with mutations in KAT6A/MOZ detected by whole-exome sequencing. All five different de novo heterozygous truncating mutations were located in the C-terminal transactivation domain of KAT6A: NM_001099412.1: c.3116_3117 delCT, p.(Ser1039∗); c.3830_3831insTT, p.(Arg1278Serfs∗17); c.3879 dupA, p.(Glu1294Argfs∗19); c.4108G>T p.(Glu1370∗) and c.4292 dupT, p.(Leu1431Phefs∗8). An additional subject with a 0.23 MB microdeletion including the entire KAT6A reading frame was identified with genome-wide array comparative genomic hybridization. Finally, by detailed clinical characterization we provide evidence that heterozygous mutations in KAT6A cause a distinct intellectual disability syndrome. The common phenotype includes hypotonia, intellectual disability, early feeding and oromotor difficulties, microcephaly and/or craniosynostosis, and cardiac defects in combination with subtle facial features such as bitemporal narrowing, broad nasal tip, thin upper lip, posteriorly rotated or low-set ears, and microretrognathia. The identification of human subjects complements previous work from mice and zebrafish where knockouts of Kat6a/kat6a lead to developmental defects.
Copyright © 2015 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25728777      PMCID: PMC4375419          DOI: 10.1016/j.ajhg.2015.01.016

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  17 in total

1.  Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein.

Authors:  I Kitabayashi; Y Aikawa; L A Nguyen; A Yokoyama; M Ohki
Journal:  EMBO J       Date:  2001-12-17       Impact factor: 11.598

2.  Whole-exome-sequencing identifies mutations in histone acetyltransferase gene KAT6B in individuals with the Say-Barber-Biesecker variant of Ohdo syndrome.

Authors:  Jill Clayton-Smith; James O'Sullivan; Sarah Daly; Sanjeev Bhaskar; Ruth Day; Beverley Anderson; Anne K Voss; Tim Thomas; Leslie G Biesecker; Philip Smith; Alan Fryer; Kate E Chandler; Bronwyn Kerr; May Tassabehji; Sally-Ann Lynch; Malgorzata Krajewska-Walasek; Shane McKee; Janine Smith; Elizabeth Sweeney; Sahar Mansour; Shehla Mohammed; Dian Donnai; Graeme Black
Journal:  Am J Hum Genet       Date:  2011-11-11       Impact factor: 11.025

3.  Mutations in KAT6B, encoding a histone acetyltransferase, cause Genitopatellar syndrome.

Authors:  Philippe M Campeau; Jaeseung C Kim; James T Lu; Jeremy A Schwartzentruber; Omar A Abdul-Rahman; Silke Schlaubitz; David M Murdock; Ming-Ming Jiang; Edward J Lammer; Gregory M Enns; William J Rhead; Jon Rowland; Stephen P Robertson; Valérie Cormier-Daire; Matthew N Bainbridge; Xiang-Jiao Yang; Marie-Claude Gingras; Richard A Gibbs; David S Rosenblatt; Jacek Majewski; Brendan H Lee
Journal:  Am J Hum Genet       Date:  2012-01-19       Impact factor: 11.025

4.  Moz-dependent Hox expression controls segment-specific fate maps of skeletal precursors in the face.

Authors:  Justin Gage Crump; Mary E Swartz; Johann K Eberhart; Charles B Kimmel
Journal:  Development       Date:  2006-06-14       Impact factor: 6.868

5.  The monocytic leukemia zinc finger protein MOZ is a histone acetyltransferase.

Authors:  N Champagne; N Pelletier; X J Yang
Journal:  Oncogene       Date:  2001-01-18       Impact factor: 9.867

6.  MOZ is essential for maintenance of hematopoietic stem cells.

Authors:  Takuo Katsumoto; Yukiko Aikawa; Atsushi Iwama; Shinobu Ueda; Hitoshi Ichikawa; Takahiro Ochiya; Issay Kitabayashi
Journal:  Genes Dev       Date:  2006-05-15       Impact factor: 11.361

7.  Moz and retinoic acid coordinately regulate H3K9 acetylation, Hox gene expression, and segment identity.

Authors:  Anne K Voss; Caitlin Collin; Mathew P Dixon; Tim Thomas
Journal:  Dev Cell       Date:  2009-11       Impact factor: 12.270

8.  The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein.

Authors:  J Borrow; V P Stanton; J M Andresen; R Becher; F G Behm; R S Chaganti; C I Civin; C Disteche; I Dubé; A M Frischauf; D Horsman; F Mitelman; S Volinia; A E Watmore; D E Housman
Journal:  Nat Genet       Date:  1996-09       Impact factor: 38.330

9.  moz regulates Hox expression and pharyngeal segmental identity in zebrafish.

Authors:  Craig T Miller; Lisa Maves; Charles B Kimmel
Journal:  Development       Date:  2004-05       Impact factor: 6.868

10.  Further delineation of the KAT6B molecular and phenotypic spectrum.

Authors:  Tamsin Gannon; Rahat Perveen; Hélene Schlecht; Simon Ramsden; Beverley Anderson; Bronwyn Kerr; Ruth Day; Siddharth Banka; Mohnish Suri; Siren Berland; Michael Gabbett; Alan Ma; Stan Lyonnet; Valerie Cormier-Daire; Rüstem Yilmaz; Guntram Borck; Dagmar Wieczorek; Britt-Marie Anderlid; Sarah Smithson; Julie Vogt; Heather Moore-Barton; Pelin Ozlem Simsek-Kiper; Isabelle Maystadt; Anne Destrée; Jessica Bucher; Brad Angle; Shehla Mohammed; Emma Wakeling; Sue Price; Amihood Singer; Yves Sznajer; Annick Toutain; Damien Haye; Ruth Newbury-Ecob; Melanie Fradin; Julie McGaughran; Beyhan Tuysuz; Mark Tein; Katelijne Bouman; Tabib Dabir; Jenneke Van den Ende; Ho Ming Luk; Daniela T Pilz; Jacqueline Eason; Sally Davies; Willie Reardon; Livia Garavelli; Orsetta Zuffardi; Koen Devriendt; Ruth Armstrong; Diana Johnson; Martine Doco-Fenzy; Emilia Bijlsma; Sheila Unger; Hermine E Veenstra-Knol; Jürgen Kohlhase; Ivan F M Lo; Janine Smith; Jill Clayton-Smith
Journal:  Eur J Hum Genet       Date:  2014-11-26       Impact factor: 4.246

View more
  45 in total

Review 1.  Neurodevelopmental and Psychiatric Symptoms in Patients with a Cyst Compressing the Cerebellum: an Ongoing Enigma.

Authors:  Xavier Guell; Sheeba A Anteraper; Satrajit S Ghosh; John D E Gabrieli; Jeremy D Schmahmann
Journal:  Cerebellum       Date:  2020-02       Impact factor: 3.847

Review 2.  Next-Generation Sequencing in Intellectual Disability.

Authors:  Gemma L Carvill; Heather C Mefford
Journal:  J Pediatr Genet       Date:  2015-10-12

3.  A Novel De Novo Frameshift Mutation in KAT6A Identified by Whole Exome Sequencing.

Authors:  Asem Alkhateeb; Wafa Alazaizeh
Journal:  J Pediatr Genet       Date:  2018-12-26

4.  Novel Causative Variants in DYRK1A, KARS, and KAT6A Associated with Intellectual Disability and Additional Phenotypic Features.

Authors:  Clark R Murray; Samantha N Abel; Matthew B McClure; Joseph Foster; Maria I Walke; Parul Jayakar; Guney Bademci; Mustafa Tekin
Journal:  J Pediatr Genet       Date:  2017-02-14

5.  Mutations in the Chromatin Regulator Gene BRPF1 Cause Syndromic Intellectual Disability and Deficient Histone Acetylation.

Authors:  Kezhi Yan; Justine Rousseau; Rebecca Okashah Littlejohn; Courtney Kiss; Anna Lehman; Jill A Rosenfeld; Constance T R Stumpel; Alexander P A Stegmann; Laurie Robak; Fernando Scaglia; Thi Tuyet Mai Nguyen; He Fu; Norbert F Ajeawung; Maria Vittoria Camurri; Lin Li; Alice Gardham; Bianca Panis; Mohammed Almannai; Maria J Guillen Sacoto; Berivan Baskin; Claudia Ruivenkamp; Fan Xia; Weimin Bi; Megan T Cho; Thomas P Potjer; Gijs W E Santen; Michael J Parker; Natalie Canham; Margaret McKinnon; Lorraine Potocki; Jennifer J MacKenzie; Elizabeth R Roeder; Philippe M Campeau; Xiang-Jiao Yang
Journal:  Am J Hum Genet       Date:  2016-12-08       Impact factor: 11.025

6.  Missense variants in the chromatin remodeler CHD1 are associated with neurodevelopmental disability.

Authors:  Genay O Pilarowski; Hilary J Vernon; Carolyn D Applegate; Leandros Boukas; Megan T Cho; Christina A Gurnett; Paul J Benke; Erin Beaver; Jennifer M Heeley; Livija Medne; Ian D Krantz; Meron Azage; Dmitriy Niyazov; Lindsay B Henderson; Ingrid M Wentzensen; Berivan Baskin; Maria J Guillen Sacoto; Gregory D Bowman; Hans T Bjornsson
Journal:  J Med Genet       Date:  2017-09-02       Impact factor: 6.318

7.  BRPF1 is essential for development of fetal hematopoietic stem cells.

Authors:  Linya You; Lin Li; Jinfeng Zou; Kezhi Yan; Jad Belle; Anastasia Nijnik; Edwin Wang; Xiang-Jiao Yang
Journal:  J Clin Invest       Date:  2016-08-08       Impact factor: 14.808

Review 8.  Regulation of KAT6 Acetyltransferases and Their Roles in Cell Cycle Progression, Stem Cell Maintenance, and Human Disease.

Authors:  Fu Huang; Susan M Abmayr; Jerry L Workman
Journal:  Mol Cell Biol       Date:  2016-06-29       Impact factor: 4.272

9.  Mutations in Histone Acetylase Modifier BRPF1 Cause an Autosomal-Dominant Form of Intellectual Disability with Associated Ptosis.

Authors:  Francesca Mattioli; Elise Schaefer; Alex Magee; Paul Mark; Grazia M Mancini; Klaus Dieterich; Gretchen Von Allmen; Marielle Alders; Charles Coutton; Marjon van Slegtenhorst; Gaëlle Vieville; Mark Engelen; Jan Maarten Cobben; Jane Juusola; Aurora Pujol; Jean-Louis Mandel; Amélie Piton
Journal:  Am J Hum Genet       Date:  2016-12-08       Impact factor: 11.025

10.  A KAT6A variant in a family with autosomal dominantly inherited microcephaly and developmental delay.

Authors:  Joanne Trinh; Irina Hüning; Zafer Yüksel; Nadja Baalmann; Sophie Imhoff; Christine Klein; Arndt Rolfs; Gabriele Gillessen-Kaesbach; Katja Lohmann
Journal:  J Hum Genet       Date:  2018-06-13       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.